Legis Daily

International Pharmaceutical Transparency Act of 2019

USA116th CongressHR-5381| House 
| Updated: 12/11/2019
Scott DesJarlais

Scott DesJarlais

Republican Representative

Tennessee

Health Subcommittee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
International Pharmaceutical Transparency Act of 2019 This bill prohibits the sale of a drug if its label fails to list the country of origin of each of the drug's active ingredients.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Dec 10, 2019
Introduced in House
Dec 10, 2019
Referred to the House Committee on Energy and Commerce.
Dec 11, 2019
Referred to the Subcommittee on Health.
  • December 10, 2019
    Introduced in House
  • December 10, 2019
    Referred to the House Committee on Energy and Commerce.
  • December 11, 2019
    Referred to the Subcommittee on Health.

Health

Consumer affairsDrug safety, medical device, and laboratory regulationPrescription drugs

International Pharmaceutical Transparency Act of 2019

USA116th CongressHR-5381| House 
| Updated: 12/11/2019
International Pharmaceutical Transparency Act of 2019 This bill prohibits the sale of a drug if its label fails to list the country of origin of each of the drug's active ingredients.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Dec 10, 2019
Introduced in House
Dec 10, 2019
Referred to the House Committee on Energy and Commerce.
Dec 11, 2019
Referred to the Subcommittee on Health.
  • December 10, 2019
    Introduced in House
  • December 10, 2019
    Referred to the House Committee on Energy and Commerce.
  • December 11, 2019
    Referred to the Subcommittee on Health.
Scott DesJarlais

Scott DesJarlais

Republican Representative

Tennessee

Health Subcommittee, Energy and Commerce Committee

Health

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Consumer affairsDrug safety, medical device, and laboratory regulationPrescription drugs